Neo Ivy Capital Management Adma Biologics, Inc. Transaction History
Neo Ivy Capital Management
- $293 Million
- Q1 2025
A detailed history of Neo Ivy Capital Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 20,944 shares of ADMA stock, worth $294,682. This represents 0.14% of its overall portfolio holdings.
Number of Shares
20,944
Previous 297,627
92.96%
Holding current value
$294,682
Previous $5.1 Million
91.87%
% of portfolio
0.14%
Previous 1.03%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
401Shares Held
197MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$301 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$262 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$180 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$170 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$83.2 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.76B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...